Australia to continue AstraZeneca vaccination despite blood clotting case

Australia will continue its inoculation programme with AstraZeneca PLC, health officials said on Saturday, after a blood clotting case raised concern about the safety of the vaccine. A 44-year-old man was admitted to a Melbourne hospital with clotting, days after receiving the AstraZeneca vaccine, suffering serious thrombosis, a condition that prevents normal blood flow through the circulatory system.

The Therapeutic Goods Administration (TGA) regulator and a panel, the Australian Technical Advisory Group on Immunisation (ATAGI), met late Friday and early Saturday to discuss further advice on the AstraZeneca vaccine...